Abstract
Twenty-two premature lambs (gestational age 124–125 days, term 144–160 days) were intubated and supported by infant ventilators immediately after delivery. Respiratory rate was 60/min, inspiratory time 0.4s, peak inspiratory pressure (PIP) 35 cm H2O, positive endexpiratory pressure (PEEP) 2 cm H2O, FiO2 1.0. 15 min after delivery 10 lambs (group 1) were treated with 35 mg/kg body weight bovine surfactant (SF-RI 1), whereas 1 ml/kg body weight saline was instilled in 12 lambs as controls (group 2). Sequential measurements of blood gases and acid base status (every 30 min) as well as continuous registration of PIP, PEEP, respiratory rate and tidal volume (TV) were performed in all lambs for 300 min. PIP was varied between 20 and 40 cm H2O in order to attain paCO2 values between 35 and 50 mm Hg. Significantly improved oxygenation was observed in group 1 lambs with maximum differences 30 min after delivery for 2 h. Ventilation was likewise affected: paCO2 and PIP values were significantly lower in the surfactant-treated animals (group 1). Total lung-thorax compliances (calculated from TV and Δ P, i.e. PIP-PEEP) per kg body weight also significantly reflected the improvement of pulmonary function in group 1 compared to group 2 lambs. Intratracheal instillation of SF-RI 1 improved gas exchange in premature lambs, whereas control animals exhibited severe respiratory failure characteristic of respiratory distress syndrome (RDS).
Similar content being viewed by others
Abbreviations
- FiO2 :
-
fraction of inspired oxygen
- PEEP:
-
positive, end-expiratory pressure
- PIP:
-
peak inspiratory pressure
- RDS:
-
respiratory distress syndrome
- SF-RI 1:
-
bovine surfactant
- TV:
-
tidal volume
References
Adams FH, Tower B, Osher AB, Ikegami M, Fujiwara T, Nozaki M (1978) Effects of tracheal instillation of natural surfactant in premature lambs. I. Clinical and autopsy findings. Pediatr Res 12: 841–848
Avery M, Mead J (1959) Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 97:517–523
Collaborative European Multicenter Study Group (1988) Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Pediatrics 82:683–691
Disse B, Weller E, Lützen L, Ziegler H, Eberhardt H (1988) Comparison between natural and artificial surfactant preparations in premature rabbit fetuses. In: Lachmann B (ed) Surfactant replacement therapy. Springer, Berlin Heidelberg New York, pp 42–46
Disse B, Weller E, Ziegler H (1989) Composition and physiological activity of various natural and artificial surfactants for substitution. Exp Lung Res (in press)
Enhorning G, Shennan A, Possmayer F, Dunn M, Chen CP, Milligan J (1985) Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial. Pediatrics 76:145–153
Fuchimukai T, Fujiwara T, Takahashi A, Enhorning G (1987) Artificial pulmonary surfactant inhibited by proteins. J Appl Physiol 62:429–437
Gitlin JD, Soll RF, Parad RB, Horbar JD, Feldman HA, Lucey JF, Taeusch HW (1987) Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. Pediatrics 790:31–37
Glatz T, Ikegami M, Jobe A (1982) Metabolism of exogeneously administered natural surfactant in the newborn lamb. Pediatr Res 16:711–715
Hallman M, Merritt TA, Jarvenpaa AL, Boynton B, Mannino F, Gluck L, Moore T, Edwards D (1985) Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial. J Pediatr 106:963–969
Heicher DA, Kasting DS, Harrod JR (1981) Prospective clinical comparison of two methods for mechanical ventilation of neonates: rapid rate and short inspiratory time versus slow rate and long inspiratory time. J Pediatr 98:957–961
Ikegami M, Hesterberg T, Mozaki M, Adams FH (1977) Restoration of lung pressure-volume characteristics with surfactant: comparison of nebulization versus instillation and natural versus synthetic surfactant. Pediatr Res 11:178–182
Ikegami M, Adams FH, Towers B, Osher AB (1980) The quantity of natural surfactant necessary to prevent respiratory distress syndrome in premature lambs. Pediatr Res 14:1082–1085
Ikegami M, Jobe A, Glatz T (1981) Surface activity following natural surfactant treatment in premature lambs. J Appl Physiol 51:306–312
Ikegami M, Jobe A, Jacobs H, Jones SJ (1981) Sequential treatments of premature lambs with an artificial and natural surfactant. J Clin Invest 68:491–496
Ikegami M, Jobe A, Jacobs H, Lam R (1984) A protein from airways of premature lambs that inhibits surfactant function. J Appl Physiol 57:1134–1142
Ikegami M, Jobe A, Berry D (1986) A protein that inhibits surfactant in respiratory distress syndrome. Biol Neonate 50:121–129
Jacobs H, Jobe A, Ikegami M, Conaway D (1983) The significance of reutilization of surfactant phosphotidylcholine. J Biol Chem 258:4159–4165
Jobe A, Ikegami M, Glatz T, Yoshida Y, Diakomanolis E, Padbury J (1981) Duration and characteristics of treatment of premature lambs with natural surfactant. J Clin Invest 67:370–375
King RJ, Clements JA (1972) Surface active materials from dog lung. II. Composition and physiological correlations. III. Thermal analysis. Am J Physiol 223:715–733
Kwong MS, Egan EA, Notter RH, Shapiro DL (1985) Double blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Pediatrics 76:585–592
Merritt TA, Hallman M, Bloom BT, Berry C, Benirschke K, Sahn D, Key T, Edwards D, Jarvenpaa AL, Pohjavuori M, Kankaanpaa K, Kunnas M, Paatero H, Rapola J, Jaaskelainen J (1986) Prophylactic treatment of very premature infants with human surfactant. N Engl J Med 315:785–790
Notter RH, Egan EA, Kwong MS, Holm BA, Shapiro DL (1985) Lung surfactant replacement in premature lambs with extracted lipids from bovine lung lavage: effects of dose, dispersion technique and gestational age. Pediatr Res 19:569–577
Raju T, Bhat R, McCullock KM, Maeta H, Vidyasagar D, Sobel D, Anderson M, Levy P, Furner S (1987) Double-blind controlled trial of single-dose treatment with bovine surfactant in severe hyaline membrane disease. Lancet I:651–656
Reynolds EO, Jacobson HN, Motoyama EK, Kikkawa Y, Craig JM, Orzalesi MM, Cook CD (1965) The effect of immaturity and prenatal asphyxia on the lungs and pulmonary function of newborn lambs: the experimental production of respiratory distress. Pediatrics 35:382–392
Robillard EY, Alarie Y, Degenais Perusse P, Baril E, Guibeault A (1964) Microaerosol administration of synthetic dipalmitoyl lecithin in the respiratory distress syndrome: a preliminary report. Can Med Assoc J 90:55–57
Shaffer TH, Koen PA, Moskowitz GT, Ferguson JD, Delivoria-Papadopoulos M (1978) Positive end-expiratory pressure: effects on lung mechanics of premature lambs. Biol Neonate 34:1–10
Shapiro DL, Notter RH, Morin FC III, Deluga KS, Golub LM, Sinkin RA, Weiss KI, Cox C (1985) Double-blind, randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome. Pediatrics 76:593–599
Stahlman M, Le Quire VS, Young WC, Merrill RE, Birmingham RT, Payne GA, Gray J (1964) Pathophysiology of respiratory distress in newborn lambs. Am J Dis Child 108:375–392
Taeusch HW Jr, Clements J, Benson B (1983) Exogenous surfactant for human lung disease. Current status. Am Rev Resp Dis 128:791–794
Walther FJ, Blanco CE, Houdijk M, Bevers EM (1985) Single versus repetitive doses of natural surfactant as treatment of respiratory distress syndrome in premature lambs. Pediatr Res 19: 224–227
Yu S, Harding PGR, Smith N, Possmayer F (1983) Bovine pulmonary surfactant: Chemical composition and physical properties. Lipids 18:522–529
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gortner, L., Pohlandt, F., Disse, B. et al. Effects of bovine surfactant in premature lambs after intra-tracheal application. Eur J Pediatr 149, 280–283 (1990). https://doi.org/10.1007/BF02106295
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02106295